Matinas BioPharma Holdings (MTNB) Change in Acquisitions & Divestments (2020 - 2024)

Matinas BioPharma Holdings (MTNB) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $500000.0 in Q4 2024.

• Change in Acquisitions & Divestments for Q4 2024 came in at $500000.0, down 83.11% year-over-year; the trailing twelve-month figure through Dec 2024 was $17.6 million (up 31.09% YoY), and the FY2024 annual result was $17.6 million, up 31.09% from the prior year.
• Change in Acquisitions & Divestments slipped to $500000.0 in Q4 2024 per MTNB's latest filing, from $10.1 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $14.4 million in Q2 2020 and troughed at $500000.0 in Q4 2024.
• A 5-year average of $6.2 million and a median of $6.0 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• On a YoY basis, Change in Acquisitions & Divestments climbed as much as 822.27% in 2024 and fell as far as 83.11% in 2024.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $7.0 million in 2020, then decreased by 21.37% to $5.5 million in 2021, then grew by 9.09% to $6.0 million in 2022, then plunged by 50.67% to $3.0 million in 2023, then slumped by 83.11% to $500000.0 in 2024.
• Business Quant data shows MTNB's Change in Acquisitions & Divestments at $500000.0 in Q4 2024, $10.1 million in Q3 2024, and $5.0 million in Q2 2024.